Search results :

Ciclesonide

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: R03BA08

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8
Nasopharyngitis 3.7% - 10.5% 3.3% - 7.5% x x x x x x
Headache 0.4% - 11% 0.5% - 7.3% x x x x x x x x
Sinusitis 3.1% - 5.5% 3% x x x x
Epistaxis 2.7% - 11.4% 2.1% - 6.3% x x x x x x
Nasal discomfort 3.17% - 5.7% 1.79% x x x x x x
Pharyngolaryngeal pain 0.4% - 4.7% 3.3% - 4.3% x x x x x x
Nasal passage irritation 2.4% - 4.3% 2.2% - 3.6% x
Arthralgia 0.9% - 3.5% 1% x
Nasal congestion postmarketing, 1.8% - 5.5% 1.6% x x x x
Pain in extremity 0.3% - 3.1% 1% x
Ear pain 2.2% 0.6% x x x x
Bronchospasm paradoxical 1.6% - 1.8% 1.9% x
Back pain 0.6% - 3.1% 2% x x x x
Dysphonia 0.9% - 1% 0.4% x x
Hoarseness 0.9% 0.4% x x
Oral candidiasis 0.5% - 0.6% 0.4% x x
Nasal dryness 0.4% x x
Dysgeusia 0.2% - 0.4% 0.1% x x
White blood cell count increased 0.3% x
Nausea 0.2% x x x
Rhinitis 0.2% x x
Nasal septum disorder 0.2% x
Throat irritation 0.1% - 0.3% 0% x x
Dry throat 0.1% - 0.2% 0% x x
Candida infection 0.1% - 0.2% x x
Contusion 0.1% x
Dyspepsia 0.1% - 0.2% x x
Rash 0.1% x
Palpitations 0.1% x
Pharyngitis 0.1% 0% x x
Weight increased 0.1% x
Dry mouth 0.1% - 0.2% x x x
Gamma-glutamyltransferase increased 0.1% x
Alanine aminotransferase increased 0.1% x
Cataract subcapsular 0.1% x
Oral fungal infection 0.1% 0% x
Dizziness postmarketing, 0.1% x x x x x
Angioedema postmarketing x x x
Infection postmarketing x x x x
Type IV hypersensitivity reaction postmarketing x x x
Immune system disorder postmarketing x
Swelling postmarketing x x
Nasal ulcer postmarketing x x x x x x
Hyperadrenocorticism x
Bronchospasm x
Bronchitis x x x
Chest pain x
Conjunctivitis x
Cough x x x x x
Diabetes mellitus x
Dyspnoea x
Fatigue x
Fracture x
Gastroenteritis x
Gastrointestinal disorder x
Haemorrhage x
Hypertension x
Influenza x x x x
Mediastinal disorder x x
Osteopenia x
Osteoporosis x
Pneumonia x
Pharyngitis streptococcal x
Sinus headache x
Tonsillitis x
Ulcer x
Upper respiratory tract infection x
Urinary tract infection x x x
Urticaria x
Wheezing x
Muscle strain x
Cataract x x x x x
Impaired healing x x x
Intraocular pressure increased x
Chest discomfort x x
Nasal septum perforation x x x x x x
Lip swelling x
Secondary adrenocortical insufficiency x
Candida albicans infection x x x x
Viral upper respiratory tract infection x
Laboratory test abnormal x
Musculoskeletal chest pain x
Face oedema x
Obstructive airways disorder x
Ear infection x
Infestation NOS x
Rhinorrhoea x
Oropharyngeal pain x
Rhinitis allergic x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

CICLESONIDE / OMNARIS

Side effects:20
Source:Health Canada

CICLESONIDE / OMNARIS

Side effects:7
Source:FDA

CICLESONIDE / OMNARIS

Side effects:9
Source:FDA

ciclesonide

Side effects:19
Source:FDA Structured Product Label

CICLESONIDE

Side effects:19
Source:FDA Structured Product Label

ciclesonide

Side effects:33
Source:FDA Structured Product Label

CICLESONIDE

Side effects:37
Source:FDA Structured Product Label

CICLESONIDE / ALVESCO

Side effects:43
Source:Health Canada

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label